|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables, net of allowance for doubtful accounts | ||||||||||||||||||||
| Inventories: | ||||||||||||||||||||
| Finished goods | ||||||||||||||||||||
| Work in process | ||||||||||||||||||||
| Raw materials | ||||||||||||||||||||
| Total inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Land and improvements | ||||||||||||||||||||
| Building and improvements | ||||||||||||||||||||
| Machinery and equipment | ||||||||||||||||||||
| Property, plant and equipment, at cost | ||||||||||||||||||||
| Less accumulated depreciation | ||||||||||||||||||||
| Net property, plant and equipment | ||||||||||||||||||||
| Intangible assets, at cost less accumulated amortization | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and shareholders’ equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Payables | ||||||||||||||||||||
| Accrued compensation and employee benefits | ||||||||||||||||||||
| Warranty and after-sale costs, current | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term deferred revenue | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Accrued non-pension postretirement benefits | ||||||||||||||||||||
| Other accrued employee benefits | ||||||||||||||||||||
| Warranty and after-sale costs, long-term | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common stock, $1 par, authorized 80,000,000, issued 37,221,098 shares in 2026 and 2025 | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Reinvested earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Less: Treasury stock, at cost, 8,657,446 shares in 2026 and 7,834,360 in 2025 | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity |
Loading...
